olynth 0,5 mg/ml deguna aerosols, šķīdums
mcneil healthcare (ireland) limited, ireland - ksilometazolīna hidrohlorīds - deguna aerosols, šķīdums - 0,5 mg/ml
olynth 1 mg/ml deguna aerosols, šķīdums
mcneil healthcare (ireland) limited, ireland - ksilometazolīna hidrohlorīds - deguna aerosols, šķīdums - 1 mg/ml
olynth ha 1 mg/ml deguna aerosols bez konservantiem, šķīdums
mcneil healthcare (ireland) limited, ireland - ksilometazolīna hidrohlorīds - deguna aerosols, šķīdums - 1 mg/ml
olynth 1 mg/ml deguna pilieni, šķīdums
mcneil healthcare (ireland) limited, ireland - ksilometazolīna hidrohlorīds - deguna pilieni, šķīdums - 1 mg/ml
olynth ha 0,5 mg/ml deguna aerosols bez konservantiem, šķīdums
mcneil healthcare (ireland) limited, ireland - ksilometazolīna hidrohlorīds - deguna aerosols, šķīdums - 0,5 mg/ml
olydex 1 mg/50 mg/ml deguna aerosols, šķīdums
mcneil healthcare (ireland) limited, ireland - xylometazolini hydrochloridum, dexpanthenolum - deguna aerosols, šķīdums - 1 mg/50 mg/ml
olydex 0,5 mg/50 mg/ml deguna aerosols, šķīdums
mcneil healthcare (ireland) limited, ireland - xylometazolini hydrochloridum, dexpanthenolum - deguna aerosols, šķīdums - 0,5 mg/50 mg/ml
vydura
pfizer europe ma eeig - rimegepant - migrēnas traucējumi - antimigraine preparations, calcitonin gene-related peptide (cgrp) antagonists - vydura is indicated for theacute treatment of migraine with or without aura in adults;preventative treatment of episodic migraine in adults who have at least 4 migraine attacks per month.
vyepti
h. lundbeck a/s - eptinezumab - migrēnas traucējumi - pretsāpju līdzekļi - vyepti is indicated for the prophylaxis of migraine in adults who have at least 4 migraine days per month.
olimp labs® erekton™ ultra (paziņots 2013.) kapsula
olimp laboratories sp. z.o.o. - kapsula